The net result was a significant increase in TRAIL-mediated killing of B-CLL cells, such that over 30% of B-CLL cells became Annexin-V+ during the 4 hours TRAIL incubation period. This evidence concerns the gene ANXA5 and B-cell chronic lymphocytic leukemia.